Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 301–400 of 1,133
The evolving concept of cancer and metastasis stem cells
Baccelli, I., & Trumpp, A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201202014 · Cited by 412
“Recent work on induced pluripotent stem cells (iPS) has demonstrated that, contrary to all expectations, the acquisition of self-renewal and pluripotency starting from any cell type can be achieved by activation of as few as four transcription factors (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2…”
Spatially resolved multiomics of human cardiac niches
Kanemaru, K., Cranley, J., Muraro, D., Miranda, A. M. A., Ho, S. Y., Wilbrey-Clark, A., Patrick Pett, J., Polanski, K., Richardson, L., Litvinukova, M., et al. (2023) · Nature · doi:10.1038/s41586-023-06311-1 · Cited by 425
“In brief, IMR90 hiPSCs from WiCell 88 were seeded onto plates coated with Matrigel (Corning, 356231) in TeSR-E8 medium (StemCell Technologies, 05990) with 10 μM Y-27632 dihydrochloride (Sigma-Aldrich, Y0503).”
Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells
Okano, H., Nakamura, M., Yoshida, K., Okada, Y., Tsuji, O., Nori, S., Ikeda, E., Yamanaka, S., & Miura, K. (2013) · Circulation Research · doi:10.1161/circresaha.111.256149 · Cited by 414
“lentiviral-mediated gene transfer method that used a combination of Oct4, Sox2, c-Myc, and Klf4(2) or Oct4, Sox2, Nanog, and Lin28.(3) These reports stimulated enormous interest in iPSC”
MethodSomers, A., Jean, J.-C., Sommer, C. A., Omari, A., Ford, C. C., Mills, J. A., Ying, L., Sommer, A. G., Jean, J. M., Smith, B. W., et al. (2010) · Stem Cells · doi:10.1002/stem.495 · Cited by 423
The promise of human induced pluripotent stem cells for research and therapy
Nishikawa, S.-I., Goldstein, R. A., & Nierras, C. R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2466 · Cited by 421
Generation of Induced Pluripotent Stem Cells from Human Cord Blood Using OCT4 and SOX2
Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodríguez-Pizà, I., Vassena, R., Raya, A., Boué, S., Barrero, M. J., Corbella, B. A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.008 · Cited by 408
“…and human fibroblasts were the first cell types successfully reprogrammed by ectopic expression of OCT4, SOX2, KLF4, and c-MYC (OSKM) (Lowry et al., 2008; Maherali et al., 2007; Park et al., 2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundInfluentialEngineered materials for organoid systems
Kratochvil, M. J., Seymour, A. J., Li, T. L., Paşca, S. P., Kuo, C. J., & Heilshorn, S. C. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0129-9 · Cited by 414
Carr, A.-J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., Buchholz, D. E., Ahmado, A., Semo, M., Smart, M. J. K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008152 · Cited by 413
“iPS cells, derived from the IMR-90 human foetal lung fibroblast cell line[18], were cultured in stem cell medium lacking bFGF to encourage the spontaneous differentiation of cells (Fig.”
BackgroundMethodInfluentialNeural stem cells: balancing self-renewal with differentiation
Doe, C. Q. (2008) · Development · doi:10.1242/dev.014977 · Cited by 420
Generation of induced pluripotent stem cells from urine
Zhou, T., Benda, C., Duzinger, S., Huang, Y., Li, X., Li, Y., Guo, X., Cao, G., Chen, S., Hao, L., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010106 · Cited by 421
Ungrin, M. D., Joshi, C., Nica, A., Bauwens, C., & Zandstra, P. W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001565 · Cited by 413
“[58,59].”
Urbach, A., Bar-Nur, O., Daley, G. Q., & Benvenisty, N. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.005 · Cited by 407
“These induced pluripotent stem cells (iPSCs) show remarkable similarity to human ESCs (Lowry et al., 2008; Park et al., 2008c; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundMali, P., Chou, B.-K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., et al. (2010) · Stem Cells · doi:10.1002/stem.402 · Cited by 417
“We focused on the gained expression of 25 genes that are highly enriched in hES and iPS cells as compared with IMR90 cells [9] (Fig.”
MethodResultDerivation of functional retinal pigmented epithelium from induced pluripotent stem cells
Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V., & Clegg, D. O. (2009) · Stem Cells · doi:10.1002/stem.189 · Cited by 417
Kong, D., Banerjee, S., Ahmad, A., Li, Y., Wang, Z., Sethi, S., & Sarkar, F. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012445 · Cited by 411
“It is well known that co-expression of Sox2, Nanog, Oct4 and Lin28 or Oct4, Sox2, Klf4 and c-myc in human or mouse somatic cells can reprogram these somatic cells into pluripotent embryonic stem-like cells [4,5,39].”
BackgroundGeneration of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig
Esteban, M. A., Xu, J., Yang, J., Peng, M., Qin, D., Li, W., Jiang, Z., Chen, J., Deng, K., Zhong, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008938 · Cited by 418
Reprogramming of Pancreatic β Cells into Induced Pluripotent Stem Cells
Stadtfeld, M., Brennand, K., & Hochedlinger, K. (2008) · Current Biology · doi:10.1016/j.cub.2008.05.010 · Cited by 403
Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D. M., Jang, Y.-Y., Dang, C. V., Spivak, J. L., Moliterno, A. R., & Cheng, L. (2009) · Blood · doi:10.1182/blood-2009-04-217406 · Cited by 399
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
Saha, K., & Jaenisch, R. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.009 · Cited by 411
Generation of human-induced pluripotent stem cells
Park, I.-H., Lerou, P. H., Zhao, R., Huo, H., & Daley, G. Q. (2008) · Nature Protocols · doi:10.1038/nprot.2008.92 · Cited by 402
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Chang, T.-C., Zeitels, L. R., Hwang, H.-W., Chivukula, R. R., Wentzel, E. A., Dews, M., Jung, J., Gao, P., Dang, C. V., Beer, M. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808300106 · Cited by 407
“Lin-28 can substitute for Myc in the formation of these induced pluripotent stem (iPS) cells (45).”
BackgroundChromatin Connections to Pluripotency and Cellular Reprogramming
Orkin, S. H., & Hochedlinger, K. (2011) · Cell · doi:10.1016/j.cell.2011.05.019 · Cited by 399
“The finding that ectopic expression of LIN28, which is critical for the biogenesis of let-7, is sufficient to reprogram somatic cells in combination with OCT4, SOX2, and NANOG (Yu et al., 2007) is in further accordance with this result.”
ResultSpecification of transplantable astroglial subtypes from human pluripotent stem cells
Krencik, R., Weick, J. P., Liu, Y., Zhang, Z.-J., & Zhang, S.-C. (2011) · Nature Biotechnology · doi:10.1038/nbt.1877 · Cited by 404
“HESCs (line H9, passages 20-30; H7, passages 35-40) and iPSCs ((IMR90)-4”
BackgroundLamba, D. A., McUsic, A., Hirata, R. K., Wang, P.-R., Russell, D., & Reh, T. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008763 · Cited by 394
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
“man fibroblasts to a pluripotent state with the ability to generate the three embryonic layers (Takahashi et al., 2007; Yu et al., 2007).”
Hu, G.-W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S.-M., Guo, S.-C., Lang, H.-L., Zhang, C.-Q., Wang, Y., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/scrt546 · Cited by 391
“In contrast to iPSCs and ESCs, iMSCs expressed no pluripotency genes, such as Nanog and Oct4, which are thought to be essential for maintaining the function of iPSCs and ESCs [44].”
ResultDirect reprogramming of somatic cells is promoted by maternal transcription factor Glis1
Maekawa, M., Yamaguchi, K., Nakamura, T., Shibukawa, R., Kodanaka, I., Ichisaka, T., Kawamura, Y., Mochizuki, H., Goshima, N., & Yamanaka, S. (2011) · Nature · doi:10.1038/nature10106 · Cited by 388
Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration
Kadoya, K., Lu, P., Nguyen, K., Lee-Kubli, C., Kumamaru, H., Yao, L., Knackert, J., Poplawski, G., Dulin, J. N., Strobl, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4066 · Cited by 395
“…University of Wisconsin-Madison, passage 28–30) were maintained on a feeder layer of irradiated mouse embryonic fibroblasts (MEFs) as described 51,52 . hiPSCs were differentiated to Pax6/Sox1-expressing neuroepithelia (NE) for 10–12 days in a neural induction medium consisting of DMEM/F12, N2…”
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Molenaar, J. J., Domingo-Fernández, R., Ebus, M. E., Lindner, S., Koster, J., Drabek, K., Mestdagh, P., van Sluis, P., Valentijn, L. J., van Nes, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2436 · Cited by 383
Epigenetic modifications in pluripotent and differentiated cells
Meissner, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1684 · Cited by 372
“Translation of the approach to human cells has allowed the generation of patient-specific stem cells and transformed the field of regenerative biolog”
BackgroundZhao, L., & Zhang, B. (2017) · Scientific Reports · doi:10.1038/srep44735 · Cited by 375
Induced pluripotent stem cells: current progress and potential for regenerative medicine
Amabile, G., & Meissner, A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.12.003 · Cited by 384
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
“Induced pluripotency involves reprogramming of somatic cells into human induced pluripotent stem cells (hiPSCs) by introducing genetic factors such as OCT4, SOX2, NANOG, and LIN28.”
Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3343 · Cited by 379
“This premise of dedifferentiation is supported by the recently described generation of pluripotent stem cells from seemingly terminally differentiated somatic cells (31, 32).”
BackgroundGenetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
An, M. C., Zhang, N., Scott, G., Montoro, D., Wittkop, T., Mooney, S., Melov, S., & Ellerby, L. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.026 · Cited by 376
“…in the advancement of reprogramming technology facilitating the more efficient and accessible generation of patient-specific iPSCs has opened the door to the development of strategies for iPSC-based disease modeling and regenerative therapy (Ye et al., 2009; Yu et al., 2007; Zou et al., 2009).”
BackgroundChemical reprogramming of human somatic cells to pluripotent stem cells.
Guan, J., Wang, G., Wang, J., Zhang, Z., Fu, Y., Cheng, L., Meng, G., Lyu, Y., Zhu, J., Li, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04593-5 · Cited by 388
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11
Vilchez, D., Boyer, L., Morantte, I., Lutz, M., Merkwirth, C., Joyce, D., Spencer, B., Page, L., Masliah, E., Berggren, W. T., et al. (2012) · Nature · doi:10.1038/nature11468 · Cited by 388
Molecules that Promote or Enhance Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells
Feng, B., Ng, J.-H., Heng, J.-C. D., & Ng, H.-H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.005 · Cited by 381
Signaling in Adult Neurogenesis
Suh, H., Deng, W., & Gage, F. H. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113256 · Cited by 375
Stem cells in dentistry – Part I: Stem cell sources
Egusa, H., Sonoyama, W., Nishimura, M., Atsuta, I., & Akiyama, K. (2012) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2012.06.001 · Cited by 374
“Just a year after the mouse study was reported, the findings were replicated in human skin cells [24,148], which opened the door to generate a patient-specific ES cell equivalent from autologous somatic cells.”
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C.-P., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 382
“In addition, RNA binding protein LIN28, which induces reprogramming by suppressing let-7 biogenesis 8, 35-37 , has been identified as a major reprogramming factor in humans.”
Directed Differentiation of Human-Induced Pluripotent Stem Cells Generates Active Motor Neurons
Karumbayaram, S., Novitch, B. G., Patterson, M., Umbach, J. A., Richter, L., Lindgren, A., Conway, A. E., Clark, A. T., Goldman, S. A., Plath, K., et al. (2009) · Stem Cells · doi:10.1002/stem.31 · Cited by 374
“Several groups have demonstrated the feasibility of reprogramming various types of human somatic cells to an embryonic state upon the introduction of pluripotency factors that yield induced pluripotent stem cells (iPS cells) [1–4].”
Generation of Pig Induced Pluripotent Stem Cells with a Drug-Inducible System
Wu, Z., Chen, J., Ren, J., Bao, L., Liao, J., Cui, C., Rao, L., Li, H., Gu, Y., Dai, H., et al. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp003 · Cited by 383
“Another type of pluripotent stem cells, known as iPS cells, can be generated by reprogramming somatic cells using defined transcription factors (Takahashi and Yamanaka, 2006; Qin et al., 2007; Yu et al., 2007; Li et al., 2009; Liao et al., 2009; Liu et al., 2008).”
BackgroundMethodInfluentialSomatic copy number mosaicism in human skin revealed by induced pluripotent stem cells
Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M. S., Tomasini, L., Ferrandino, A. F., Rosenberg Belmaker, L. A., Szekely, A., Wilson, M., et al. (2012) · Nature · doi:10.1038/nature11629 · Cited by 384
A Review of the Methods for Human iPSC Derivation
Malik, N., & Rao, M. S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-348-0_3 · Cited by 354
“(28), this study found that all iPSC lines lost the plasmid by passage 15.”
Feng, Q., Lu, S.-J., Klimanskaya, I., Gomes, I., Kim, D., Chung, Y., Honig, G. R., Kim, K.-S., & Lanza, R. (2010) · Stem Cells · doi:10.1002/stem.321 · Cited by 376
An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease
Pardo, M., Lang, B., Yu, L., Prosser, H., Bradley, A., Babu, M. M., & Choudhary, J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.004 · Cited by 379
Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming
Singhal, N., Graumann, J., Wu, G., Araúzo-Bravo, M. J., Han, D. W., Greber, B., Gentile, L., Mann, M., & Schöler, H. R. (2010) · Cell · doi:10.1016/j.cell.2010.04.037 · Cited by 378
Cardiac Stem Cell Therapy and the Promise of Heart Regeneration
Garbern, J. C., & Lee, R. T. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.05.008 · Cited by 369
Tang, C., Lee, A. S., Volkmer, J.-P., Sahoo, D., Nag, D., Mosley, A. R., Inlay, M. A., Ardehali, R., Chavez, S. L., Pera, R. R., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1947 · Cited by 375
Mitochondrial Regulation in Pluripotent Stem Cells
Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G.-H., & Izpisua Belmonte, J. C. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.005 · Cited by 374
How does Lin28 let-7 control development and disease?
Thornton, J. E., & Gregory, R. I. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.06.001 · Cited by 369
“In accordance with reestablishing a gene expression signature reminiscent of ESCs, Lin28 overexpression in conjunction with other defined factors is sufficient to reprogram somatic cells to an induced pluripotent state[19].”
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2599 · Cited by 373
Ramachandran, R., Fausett, B. V., & Goldman, D. (2010) · Nature Cell Biology · doi:10.1038/ncb2115 · Cited by 366
“We hypothesized that Muller glia dedifferentiation may have some similarities to the reprogramming of somatic cells by pluripotency factor”
BackgroundSystems biology of stem cell fate and cellular reprogramming
MacArthur, B. D., Ma'ayan, A., & Lemischka, I. R. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2766 · Cited by 371
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7
Dangi‐Garimella, S., Yun, J., Eves, E. M., Newman, M., Erkeland, S. J., Hammond, S. M., Minn, A. J., & Rosner, M. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.294 · Cited by 363
“The data presented here are supported by a recent report that let-7 inhibits tumorigenesis in a breast cancer stem cell line (Yu et al, 2007a).”
ResultA Drug-Inducible System for Direct Reprogramming of Human Somatic Cells to Pluripotency
Hockemeyer, D., Soldner, F., Cook, E. G., Gao, Q., Mitalipova, M., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.014 · Cited by 367
Lentiviral vectors: basic to translational
Sakuma, T., Barry, M. A., & Ikeda, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120146 · Cited by 336
Utikal, J., Maherali, N., Kulalert, W., & Hochedlinger, K. (2009) · Journal of Cell Science · doi:10.1242/jcs.054783 · Cited by 346
“…et al., 2008; Liu et al., 2008; Maherali et al., 2007; Okita et al., 2007; Park et al., 2008b; Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007; Wernig et al., 2007; Hochedlinger and Plath, 2009; Li et al., 2008). iPSCs acquire most of the features of embryonic stem cells…”
BackgroundForce, T., & Kolaja, K. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3252 · Cited by 363
“A plausible strategy incorporating this approach would be to create stem cells from adult cells (that is, iPS cells”
MethodBeers, J., Gulbranson, D. R., George, N., Siniscalchi, L. I., Jones, J., Thomson, J. A., & Chen, G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.130 · Cited by 357
Self-citationFunctional skeletal muscle regeneration from differentiating embryonic stem cells
Darabi, R., Gehlbach, K., Bachoo, R. M., Kamath, S., Osawa, M., Kamm, K. E., Kyba, M., & Perlingeiro, R. C. R. (2008) · Nature Medicine · doi:10.1038/nm1705 · Cited by 359
“Although the adult stem cells described above may be useful therapeutically, an ES cell–based therapy would have many advantages including, first, resetting of the developmental clock, allowing the transplantation of a more primitive cell with greater replicative potential, which would probably confer more durable eng…”
BackgroundLin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism
Shyh-Chang, N., Zhu, H., Yvanka de Soysa, T., Shinoda, G., Seligson, M. T., Tsanov, K. M., Nguyen, L., Asara, J. M., Cantley, L. C., & Daley, G. Q. (2013) · Cell · doi:10.1016/j.cell.2013.09.059 · Cited by 363
“Lin28a has also been used to reprogram human somatic cells into induced pluripotent stem (iPS) cells (Yu et al., 2007), and in mice, Lin28a overexpression delays puberty and promotes growth (Zhu et al., 2010, 2011).”
Eminli, S., Utikal, J., Arnold, K., Jaenisch, R., & Hochedlinger, K. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0317 · Cited by 351
Genetic variation in LIN28B is associated with the timing of puberty
Ong, K. K., Elks, C. E., Li, S., Zhao, J. H., Luan, J., Andersen, L. B., Bingham, S. A., Brage, S., Smith, G. D., Ekelund, U., et al. (2009) · Nature Genetics · doi:10.1038/ng.382 · Cited by 366
Molecular Basis for Interaction of let-7 MicroRNAs with Lin28
Nam, Y., Chen, C., Gregory, R. I., Chou, J. J., & Sliz, P. (2011) · Cell · doi:10.1016/j.cell.2011.10.020 · Cited by 356
“Molecular Basis for Interaction of let-7MicroRNAs with Lin28”
BackgroundZhang, Q., Jiang, J., Han, P., Yuan, Q., Zhang, J., Zhang, X., Xu, Y., Cao, H., Meng, Q., Chen, L., et al. (2011) · Cell Research · doi:10.1038/cr.2010.163 · Cited by 367
Orlova, V. V., van den Hil, F. E., Petrus-Reurer, S., Drabsch, Y., ten Dijke, P., & Mummery, C. L. (2014) · Nature Protocols · doi:10.1038/nprot.2014.102 · Cited by 365
Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts
Tateishi, K., He, J., Taranova, O., Liang, G., D'Alessio, A. C., & Zhang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806597200 · Cited by 358
Cell Delivery Mechanisms for Tissue Repair
Mooney, D. J., & Vandenburgh, H. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.02.005 · Cited by 357
“, pancreatic beta cells; Porat and Dor, 2007), and even recently the ability to reprogram human adult cells into ES cell-like pluripotent cells (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundKong, D., Li, Y., Wang, Z., & Sarkar, F. H. (2011) · Cancers · doi:10.3390/cancers30100716 · Cited by 346
“Recent studies indicated that co-expression of pluripotency markers such as Oct4, Sox2, Nanog, lin28, Klf4 and c-myc can reprogram somatic cells into pluripotent embryonic stem-like cells [48-50], suggesting that combined expression of stem cell-associated factors in cells with oncogenes could also induce an undiffere…”
BackgroundBrain organoids for the study of human neurobiology at the interface of in vitro and in vivo
Chiaradia, I., & Lancaster, M. A. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00730-3 · Cited by 348
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics
Chen, K. G., Mallon, B. S., McKay, R. D. G., & Robey, P. G. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.12.005 · Cited by 358
“…et al., 2010; Lock and Tzanakakis 2009; Fernandes et al., 2009; Oh et al., 2009; Serra et al., 2011; Ungrin et al., 2008; Siti-Ismail et al., 2008; Zweigerdt et al. 2011; Serra et al., 2012; Villa-Diaz et al., 2009 DA, low-throughput drug assay; EB, embryoid body; HTP, high-throughput assay;…”
ResultProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
Fong, C.-Y., Chak, L.-L., Biswas, A., Tan, J.-H., Gauthaman, K., Chan, W.-K., & Bongso, A. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9166-x · Cited by 345
“Attempts are being made to circumvent this problem by personalization of tissues through somatic cell nuclear transfer (NT) and human induced pluripotent stem cell (hiPSC) technology [7–9].”
BackgroundTakayama, N., Nishimura, S., Nakamura, S., Shimizu, T., Ohnishi, R., Endo, H., Yamaguchi, T., Otsu, M., Nishimura, K., Nakanishi, M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100844 · Cited by 349
“Successful reprogramming of differentiated fibroblasts into a pluripotent stage using the defined genes OCT3/4, KLF4, SOX2, and c-MYC (Takahashi et al., 2007; Yu et al., 2007) is a potentially effective means of generating HLA-matched iPSCs for regenerative medicine CORRESPONDENCE K.”
BackgroundGeneration of Induced Pluripotent Stem Cell Lines from Adult Rat Cells
Liao, J., Cui, C., Chen, S., Ren, J., Chen, J., Gao, Y., Li, H., Jia, N., Cheng, L., Xiao, H., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.013 · Cited by 355
“Another type of pluripotent stem cells called induced pluripotent stem cells (iPSCs) can be generated by reprogramming adult cells using defined transcription factors (Liao et al., 2008; Park et al., 2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
Yu, J., & Thomson, J. A. (2008) · Genes & Development · doi:10.1101/gad.1689808 · Cited by 342
Self-citationHuman naive epiblast cells possess unrestricted lineage potential
Guo, G., Stirparo, G. G., Strawbridge, S. E., Spindlow, D., Yang, J., Clarke, J., Dattani, A., Yanagida, A., Li, M. A., Myers, S., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.02.025 · Cited by 338
Tgfβ Signal Inhibition Cooperates in the Induction of iPSCs and Replaces Sox2 and cMyc
Maherali, N., & Hochedlinger, K. (2009) · Current Biology · doi:10.1016/j.cub.2009.08.025 · Cited by 348
Engineering human pluripotent stem cells into a functional skeletal muscle tissue
Rao, L., Qian, Y., Khodabukus, A., Ribar, T., & Bursac, N. (2018) · Nature Communications · doi:10.1038/s41467-017-02636-4 · Cited by 334
Sheik Mohamed, J., Gaughwin, P. M., Lim, B., Robson, P., & Lipovich, L. (2010) · RNA · doi:10.1261/rna.1441510 · Cited by 335
“Furthermore, induced expression of Oct4 (Takahashi and Yamanaka 2006) and Nanog (Yu et al. 2007) along with other key mESC-enriched regulatory proteins can promote an mESC-like phenotype in nominally lineage-restricted somatic cell populations.”
BackgroundHLA-haplotype banking and iPS cells
Nakatsuji, N., Nakajima, F., & Tokunaga, K. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-739 · Cited by 336
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Thiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70914-6 · Cited by 346
iPS Cells Reprogrammed From Human Mesenchymal-Like Stem/Progenitor Cells of Dental Tissue Origin
Yan, X., Qin, H., Qu, C., Tuan, R. S., Shi, S., & Huang, G. T.-J. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0314 · Cited by 344
“Our fi rst attempt to reprogram cells was by using the 4 factor genes (c-Myc, Klf4, Oct4, and Sox2) each subcloned into the pLenti6.”
InfluentialLIN28 Regulates Stem Cell Metabolism and Conversion to Primed Pluripotency
Zhang, J., Ratanasirintrawoot, S., Chandrasekaran, S., Wu, Z., Ficarro, S. B., Yu, C., Ross, C. A., Cacchiarelli, D., Xia, Q., Seligson, M., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.009 · Cited by 345
“Somatic cells can be reprogrammed to pluripotency by OCT4 and SOX2 together with KLF4 and c-MYC (OSKM) or NANOG and LIN28A (OSNA) (Park et al., 2008; Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007).”
Regulatory networks define phenotypic classes of human stem cell lines
Müller, F.-J., Laurent, L. C., Kostka, D., Ulitsky, I., Williams, R., Lu, C., Park, I.-H., Rao, M. S., Shamir, R., Schwartz, P. H., et al. (2008) · Nature · doi:10.1038/nature07213 · Cited by 343
Cryopreservation of Human Stem Cells for Clinical Application: A Review
Hunt, C. J. (2011) · Transfusion Medicine and Hemotherapy · doi:10.1159/000326623 · Cited by 329
A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28–let-7 pathway
Chang, H.-M., Triboulet, R., Thornton, J. E., & Gregory, R. I. (2013) · Nature · doi:10.1038/nature12119 · Cited by 341
“Lin28 is a pluripotency factor in stem cells where its expression helps maintain an undifferentiated and proliferative state by blocking let-7 expression 14,15 .”
Progress toward the clinical application of patient-specific pluripotent stem cells
Kiskinis, E., & Eggan, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40553 · Cited by 339
Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2
Li, W., Zhou, H., Abujarour, R., Zhu, S., Young Joo, J., Lin, T., Hao, E., Schöler, H. R., Hayek, A., & Ding, S. (2009) · Stem Cells · doi:10.1002/stem.240 · Cited by 328
Adult neural stem cells in the mammalian central nervous system
Ma, D. K., Bonaguidi, M. A., Ming, G.-L., & Song, H. (2009) · Cell Research · doi:10.1038/cr.2009.56 · Cited by 329
“For genetic factor-induced reprogramming of somatic cells [110,111], only one factor Oct4 is sufficient to reprogram adult NSCs into induced pluripotent stem (iPS) cells whereas most other cell types require three or four factors [111–114].”
BackgroundArticular cartilage and osteochondral tissue engineering techniques: Recent advances and challenges
Wei, W., & Dai, H. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.011 · Cited by 327
Stem Cells and Early Lineage Development
Rossant, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.039 · Cited by 324
“…factors, Oct4 and Sox2, for driving pluripotency is supported by the recent derivation of ES cell-like cells, called iPS cells, from mouse (Takahashi and Yamanaka, 2006; Maherali et al., 2007: Okita et al., 2007: Wernig et al., 2007) and human fibroblasts (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundA chemical approach to stem-cell biology and regenerative medicine
Xu, Y., Shi, Y., & Ding, S. (2008) · Nature · doi:10.1038/nature07042 · Cited by 336
Regulation of somatic cell reprogramming through inducible mir-302 expression
Lin, S.-L., Chang, D. C., Lin, C.-H., Ying, S.-Y., Leu, D., & Wu, D. T. S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq850 · Cited by 328
“The mechanism underlying this SCR process is consistent with the reported iPS cell induction using ectopic transfection of Oct3/4–Sox2–Nanog–Lin28 factors (2).”
InfluentialCancer stem cells, cancer cell plasticity and radiation therapy
Vlashi, E., & Pajonk, F. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.001 · Cited by 327
“It is noteworthy that Klf4 s dispensable for reprogramming somatic cells into pluripotency, nd together with c-Myc it can be replaced by Nanog and LIN28 [86].”
BackgroundCarey, B. W., Markoulaki, S., Hanna, J. H., Faddah, D. A., Buganim, Y., Kim, J., Ganz, K., Steine, E. J., Cassady, J. P., Creyghton, M. P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.003 · Cited by 325
“, 2009), genetic background of donor cells, unique reprogramming factor cocktails (Yu et al., 2007), and distinct proviral integrations (Wernig et al.”
BackgroundFundamentals and application of magnetic particles in cell isolation and enrichment: a review
Plouffe, B. D., Murthy, S. K., & Lewis, L. H. (2015) · Reports on Progress in Physics · doi:10.1088/0034-4885/78/1/016601 · Cited by 334
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.